Beta-lactamyl vasopressin Vlaantagonists
Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
30.07.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor. |
---|---|
Bibliography: | Application Number: AU20020342045 |